SET expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.261000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.315250E-01
Normal-vs-Stage2
6.192600E-01
Normal-vs-Stage3
2.747400E-01
Normal-vs-Stage4
8.697200E-01
Stage1-vs-Stage2
3.192000E-01
Stage1-vs-Stage3
7.866400E-01
Stage1-vs-Stage4
7.888300E-02
Stage2-vs-Stage3
2.638000E-01
Stage2-vs-Stage4
4.993000E-01
Stage3-vs-Stage4
1.888220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.587400E-01
Normal-vs-AfricanAmerican
5.181600E-01
Normal-vs-Asian
3.627200E-01
Caucasian-vs-AfricanAmerican
6.910000E-01
Caucasian-vs-Asian
5.207800E-01
AfricanAmerican-vs-Asian
9.422200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.670600E-01
Normal-vs-Female
5.822800E-01
Male-vs-Female
8.216800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.785900E-02
Normal-vs-Age(41-60Yrs)
9.059800E-01
Normal-vs-Age(61-80Yrs)
4.439400E-01
Normal-vs-Age(81-100Yrs)
6.542800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.814100E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.850400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.498200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.982140E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.540400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.156400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.857600E-01
Normal-vs-Daily Drinker
5.982800E-01
Normal-vs-Weekly Drinker
3.482600E-01
Normal-vs-Occasional Drinker
9.012800E-01
Normal-vs-Social Drinker
9.487800E-01
Non Drinker-vs-Daily Drinker
5.382200E-01
Non Drinker-vs-Weekly Drinker
8.933200E-01
Non Drinker-vs-Occasional Drinker
5.580200E-02
Non Drinker-vs-Social Drinker
1.420430E-01
Daily Drinker-vs-Weekly Drinker
6.814000E-01
Daily Drinker-vs-Occasional Drinker
2.220400E-01
Daily Drinker-vs-Social Drinker
4.016400E-01
Weekly Drinker-vs-Occasional Drinker
1.093430E-01
Weekly Drinker-vs-Social Drinker
2.154200E-01
Occasional Drinker-vs-Social Drinker
7.476800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.137400E-01
Normal-vs-Grade 2
8.063600E-01
Normal-vs-Grade 3
7.685400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.145700E-02
Grade 1-vs-Grade 3
3.944300E-02
Grade 1-vs-Grade 4
9.137400E-01
Grade 2-vs-Grade 3
4.041600E-01
Grade 2-vs-Grade 4
8.063600E-01
Grade 3-vs-Grade 4
7.685400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.569200E-01
Normal-vs-NonDiabetic
6.457000E-01
Diabetic-vs-NonDiabetic
5.399200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.298800E-01
Normal-vs-NoPancreatitis
6.529400E-01
Pancreatitis-vs-NoPancreatitis
9.451000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.834200E-01
Normal-vs-N1
6.082800E-01
N0-vs-N1
4.212000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.829800E-01
Normal-vs-TP53-NonMutant
4.841800E-01
TP53-Mutant-vs-TP53-NonMutant
3.774100E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
